| Abstrakt: |
Adenocarcinoma, Antimetabolites, Antineoplastics, Antivirals, Beta-Globulins, Blood Coagulation Factors, Blood Proteins, Cancer, Coagulation Modifiers, Drugs and Therapies, Enzyme Precursors, Enzymes and Coenzymes, Gastroenterology, Gemcitabine Therapy, Genetics, Health and Medicine, Hematology, Immunosuppressive Agents, Oncology, Pancreas, Pancreatic Cancer, Peptide Hydrolases, Pharmaceuticals, Plasminogen, Plasminogen Activators, Proteins, Radiation-Sensitizing Agents, Serine Endopeptidases, Thrombolytics, Urokinase Therapy, Urokinase-Type Plasminogen Activator Keywords: Adenocarcinoma; Antimetabolites; Antineoplastics; Antivirals; Beta-Globulins; Blood Coagulation Factors; Blood Proteins; Cancer; Coagulation Modifiers; Drugs and Therapies; Enzyme Precursors; Enzymes and Coenzymes; Gastroenterology; Gemcitabine Therapy; Genetics; Health and Medicine; Hematology; Immunosuppressive Agents; Oncology; Pancreas; Pancreatic Cancer; Peptide Hydrolases; Pharmaceuticals; Plasminogen; Plasminogen Activators; Proteins; Radiation-Sensitizing Agents; Serine Endopeptidases; Thrombolytics; Urokinase Therapy; Urokinase-Type Plasminogen Activator EN Adenocarcinoma Antimetabolites Antineoplastics Antivirals Beta-Globulins Blood Coagulation Factors Blood Proteins Cancer Coagulation Modifiers Drugs and Therapies Enzyme Precursors Enzymes and Coenzymes Gastroenterology Gemcitabine Therapy Genetics Health and Medicine Hematology Immunosuppressive Agents Oncology Pancreas Pancreatic Cancer Peptide Hydrolases Pharmaceuticals Plasminogen Plasminogen Activators Proteins Radiation-Sensitizing Agents Serine Endopeptidases Thrombolytics Urokinase Therapy Urokinase-Type Plasminogen Activator 386 386 1 03/27/23 20230331 NES 230331 2023 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on pancreatic cancer is now available. [Extracted from the article] |
